review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1002/J.1875-9114.1988.TB04069.X |
P698 | PubMed publication ID | 3050903 |
P2093 | author name string | Lam YW | |
P2860 | cites work | Interaction of clofibrate with warfarin. I. Effect of clofibrate on the disposition of the optical enantiomorphs of warfarin | Q58817421 |
Active Transport of L-Dopa in the Intestine | Q59068223 | ||
Toxicity and Teratogenicity of Optical Isomers of Thalidomide | Q59099301 | ||
Untoward effects associated with practolol administration: oculomucocutaneous syndrome | Q24674646 | ||
Possible role of antibody specific for a practolol metabolite in the pathogenesis of oculomucocutaneous syndrome | Q24675553 | ||
Effect of verapamil studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia | Q28333056 | ||
Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology | Q34054672 | ||
Bronchial beta-adrenoceptor blockade following eyedrops of timolol and its isomer L-714,465 in normal subjects | Q34446748 | ||
Plasma levels of (+) and (-)-propranolol and 4-hydroxypropranolol after administration of racemic (+/-)-propranolol in man | Q34511604 | ||
(+)-Propranolol clearance, an estimation of hepatic blood flow in man | Q34516519 | ||
Stereoselective renal clearance of pindolol in humans | Q34563398 | ||
Differentiation of Receptor Systems activated by Sympathomimetic Amines | Q34706728 | ||
Methadone binding to orosomucoid (alpha 1-acid glycoprotein): determinant of free fraction in plasma | Q34716290 | ||
Verapamil in the treatment of paroxysmal supraventricular tachycardia | Q36810365 | ||
Simultaneous determination of (–)- and (+)- propranolol by gas chromatography-mass spectrometry using a deuterium labeling technique | Q39122875 | ||
A functional basis for classification of α-adrenergic receptors | Q39165904 | ||
Cimetidine: interaction with oral anticoagulants in man | Q39559857 | ||
The Adrenergic Receptor | Q40044009 | ||
Recent advances in methods of direct optical resolution | Q40178235 | ||
Serum tocainide enantiomer concentrations in human subjects | Q40210377 | ||
Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone | Q40373479 | ||
The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias | Q41357289 | ||
Differential stereoselective metabolism of metoprolol in extensive and poor debrisoquin metabolizers | Q41588910 | ||
Warfarin metabolism in man: identification of metabolites in urine | Q41710726 | ||
The alpha- and beta-adrenoceptor blocking potencies of labetalol and its individual stereoisomers in anaesthetized dogs and in isolated tissues | Q41893893 | ||
Stereoselective binding of propranolol enantiomers to human alpha 1-acid glycoprotein and human plasma | Q41940414 | ||
Stereoselective interaction between the R enantiomer of warfarin and cimetidine | Q42073220 | ||
The warfarin-cimetidine interaction: stereochemical considerations | Q42074620 | ||
A comparison of the cardiovascular effects of (+)-sotalol and (+/-)-sotalol following intravenous administration in normal volunteers | Q42077131 | ||
Stereoselective first-pass metabolism of highly cleared drugs: studies of the bioavailability of L- and D-verapamil examined with a stable isotope technique | Q42126042 | ||
Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations | Q42246990 | ||
Pharmacokinetics of (+)-, (-)- and (+/-)-verapamil after intravenous administration | Q42532060 | ||
Modification of Parkinsonism--chronic treatment with L-dopa | Q45300970 | ||
Treatment of acute focal cerebral ischemia with propranolol | Q48948936 | ||
Effects on atrioventricular conduction and blood flow of enantiomers of verapamil and of tetrodotoxin injected into the posterior and the anterior septal artery of the atrioventricular node preparation of the dog | Q52701844 | ||
Regional hemodynamic effects of beta-adrenergic blockade with propranolol in the unanesthetized primate | Q54653336 | ||
Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man | Q54693988 | ||
Cutaneous and ocular reactions to practolol. | Q55109534 | ||
Immediate Effects of Intravenous Verapamil in Cardiac Arrhythmias | Q55359543 | ||
Effects of verapamil on P-R-intervals in relation to verapamil plasma levels following single i.v. and oral administration and during chronic treatment | Q57072042 | ||
In vivo interaction of the enantiomers of disopyramide in human subjects | Q58817353 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | stereoselectivity | Q903429 |
P304 | page(s) | 147-157 | |
P577 | publication date | 1988-01-01 | |
P1433 | published in | Pharmacotherapy | Q7180800 |
P1476 | title | Stereoselectivity: an issue of significant importance in clinical pharmacology | |
P478 | volume | 8 |
Q36176850 | A rapid and efficient analytical method for the quantification of a novel anticholinergic compound, R-phencynonate, by stable isotope-dilution LC-MS/MS and its application to bioavailability and dose proportionality studies |
Q42032895 | Age-dependent stereoselective increase in the oral clearance of hexobarbitone isomers caused by rifampicin |
Q38758099 | Dilevalol: a selective beta-2 adrenergic agonist vasodilator with beta adrenergic blocking activity |
Q37913132 | Drug interactions in hypertensive patients. Pharmacokinetic, pharmacodynamic and genetic considerations |
Q36138026 | Drug interactions: Part I |
Q44288491 | High-performance liquid-chromatographic determination of warfarin enantiomers in plasma with automated on-line sample enrichment |
Q31115254 | In vitro assessment of stereoselective hepatic metabolism of disopyramide in humans: Comparison with in vivo data |
Q68506534 | Nonsteroidal anti-inflammatory drugs |
Q35871814 | Sedation and histamine H1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene |
Q40858967 | Stereoselective and isozyme-selective drug interactions |
Q34402549 | Use of pseudoracemic nitrendipine to elucidate the metabolic steps responsible for stereoselective disposition of nitrendipine enantiomers |